SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including Omicron

The emergence of SARS-CoV-2 Omicron and other variants of concern (VOCs) has brought huge challenges to control the COVID-19 pandemic, calling for urgent development of effective vaccines and therapeutic drugs. In this study, we focused on characterizing the impacts of divergent VOCs on the antivira...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yuanmei, Dong, Xiaojing, Liu, Nian, Wu, Tong, Chong, Huihui, Lei, Xiaobo, Ren, Lili, Wang, Jianwei, He, Yuxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310806/
https://www.ncbi.nlm.nih.gov/pubmed/35786417
http://dx.doi.org/10.1080/22221751.2022.2098060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310806/
https://www.ncbi.nlm.nih.gov/pubmed/35786417
http://dx.doi.org/10.1080/22221751.2022.2098060

Ejemplares similares